-
公开(公告)号:IL316462A
公开(公告)日:2024-12-01
申请号:IL31646224
申请日:2024-10-21
Applicant: VERTEX PHARMA , MILLER MARK THOMAS , HURLEY DENNIS JAMES , NEUBERT TIMOTHY DONALD , ARUMUGAM VIJAYALAKSMI , HADIDA RUAH SARA SABINA , MCCARTNEY JASON , ZHOU JINGLAN , CHAU JACLYN , DEMORET ROBERT MARTIN , GHIRMAI SENAIT G , VALIULIN ROMAN ASKATOVICH , KINTZER ALEXANDER FREDERIK , SLOCHOWER DAVID ROBERT , AERTGEERTS KATHLEEN , BECK ELIZABETH MARY , MUI JAMES JUN BON , WRIGHT MIRANDA ADELE , KNEGTEL RONALD MARCELLUS ALPHONSUS , CHUDYK EWA IWONA , PINDER JOANNE LOUISE , DODD JAMES , SIMPSON IAIN
Inventor: MILLER MARK THOMAS , HURLEY DENNIS JAMES , NEUBERT TIMOTHY DONALD , ARUMUGAM VIJAYALAKSMI , HADIDA RUAH SARA SABINA , MCCARTNEY JASON , ZHOU JINGLAN , CHAU JACLYN , DEMORET ROBERT MARTIN , GHIRMAI SENAIT G , VALIULIN ROMAN ASKATOVICH , KINTZER ALEXANDER FREDERIK , SLOCHOWER DAVID ROBERT , AERTGEERTS KATHLEEN , BECK ELIZABETH MARY , MUI JAMES JUN BON , WRIGHT MIRANDA ADELE , KNEGTEL RONALD MARCELLUS ALPHONSUS , CHUDYK EWA IWONA , PINDER JOANNE LOUISE , DODD JAMES , SIMPSON IAIN
Abstract: Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.
-
公开(公告)号:CO2024015820A2
公开(公告)日:2024-11-28
申请号:CO2024015820
申请日:2024-11-21
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA SABINA , MCCARTNEY JASON , MILLER MARK THOMAS , ZHOU JINGLAN , ARUMUGAM VIJAYALAKSMI , CHUDYK EWA IWONA , HURLEY DENNIS JAMES , NEUBERT TIMOTHY DONALD , PINDER JOANNE LOUISE , DODD JAMES , CHAU JACLYN , DEMORET ROBERT MARTIN , GHIRMAI SENAIT G , VALIULIN ROMAN ASKATOVICH , KINTZER ALEXANDER FREDERIK , SLOCHOWER DAVID ROBERT , AERTGEERTS KATHLEEN , BECK ELIZABETH MARY , MUI JAMES JUN BON , WRIGHT MIRANDA ADELE , KNEGTEL RONALD MARCELLUS ALPHONSUS , SIMPSON IAIN
IPC: A61P9/06 , A61K31/4375 , A61K31/4709 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/517 , A61K31/541 , A61K31/55 , A61K31/553 , A61P25/02 , A61P29/00 , C07D215/233 , C07D239/91 , C07D401/04 , C07D401/14 , C07D405/14 , C07D471/04 , C07D519/00
Abstract: Se proporcionan compuestos, y sales farmacéuticamente aceptables de estos, útiles como inhibidores de canales de sodio. También se proporcionan composiciones farmacéuticas que comprenden los compuestos o sales farmacéuticamente aceptables y métodos de uso de los compuestos, sales farmacéuticamente aceptables y composiciones farmacéuticas en el tratamiento de diversos trastornos, incluido el dolor.
-